Two Sigma Investments’s Propanc Biopharma PPCB Stock Holding History

Two Sigma Investments’s Portfolio PPCB Stock Details PPCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-650	Closed	-$8.72K	–	5040
2025 Q4	$8.72K	Buy	+650	New	+$18K	﹤0.01%	4031

Other funds holding PPCB

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SCA

Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Two Sigma Investments's PPCB Position: Q1 2026 in Review

Two Sigma Investments sold out of Propanc Biopharma (PPCB) in Q1 2026, closing a stake of 650 shares — an estimated $8.72K sold.

Two Sigma Investments first reported a position in PPCB in Q4 2025 and held it in 1 quarter. The position peaked at $8.72K in Q4 2025. 6 funds tracked by Wall St. Rank hold PPCB as of Q1 2026.

Two Sigma Investments reported no remaining Propanc Biopharma position as of Q1 2026 after selling out during the quarter.
Two Sigma Investments sold 650 Propanc Biopharma shares in Q1 2026, an estimated $8.72K.
Two Sigma Investments first reported a position in Propanc Biopharma in Q4 2025 and held it in 1 quarter.
Two Sigma Investments's Propanc Biopharma position peaked at $8.72K in Q4 2025.
6 funds tracked by Wall St. Rank held Propanc Biopharma as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.